Clinical Trial Update: Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis [EARLY_Phase 1]

View source ↗

Summary

This entry describes an early Phase 1 clinical trial evaluating oral amino acid supplementation given during hemodialysis for patients with end-stage renal dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: End Stage Renal Disease | EARLY_Phase 1 | Status: RECRUITING